国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
24期
2983-2985
,共3页
翁智胜%易江华%彭洁雯%廖梦怡%李晓辉
翁智勝%易江華%彭潔雯%廖夢怡%李曉輝
옹지성%역강화%팽길문%료몽이%리효휘
慢性荨麻疹%自血疗法%咪唑斯汀%卡介菌多糖核酸
慢性蕁痳疹%自血療法%咪唑斯汀%卡介菌多糖覈痠
만성담마진%자혈요법%미서사정%잡개균다당핵산
Chronic urticaria%Autologous whole blood therapy%Mizolastine%BCG-PSN
目的 探讨三种不同方法治疗慢性荨麻疹的近、远期疗效和安全性.方法 将患者随机分为三组,三组患者均口服咪唑斯汀片10 mg,每天1次,连用36天.a组:56例,在口服基础上加用自血治疗,取患者静脉血3 ml立即肌注,隔天1次,共18次;b组:45例,在口服基础上加用卡介菌多糖核酸注射液2ml肌注,隔天1次,连用18次;c组:43例,单纯口服.在治疗结束时和结束后3个月分别进行临床疗效评价和安全性分析.结果 治疗结束时三组的有效率分别为:78.57%、76.74%、55.56%,前两组相比差异无显著性(P>0.05),而与c组比较差异均具有显著性(P<0.05).治疗结束后3个月,三组的有效率分别变为:80.36%、60.47%、37.78%,差异均具有显著性(P<0.05).结论 咪唑斯汀联合自血疗法或卡介菌多糖核酸治疗慢性荨麻疹能提高有效率、降低复发率,前者更优,不良副反应少,值得推广.
目的 探討三種不同方法治療慢性蕁痳疹的近、遠期療效和安全性.方法 將患者隨機分為三組,三組患者均口服咪唑斯汀片10 mg,每天1次,連用36天.a組:56例,在口服基礎上加用自血治療,取患者靜脈血3 ml立即肌註,隔天1次,共18次;b組:45例,在口服基礎上加用卡介菌多糖覈痠註射液2ml肌註,隔天1次,連用18次;c組:43例,單純口服.在治療結束時和結束後3箇月分彆進行臨床療效評價和安全性分析.結果 治療結束時三組的有效率分彆為:78.57%、76.74%、55.56%,前兩組相比差異無顯著性(P>0.05),而與c組比較差異均具有顯著性(P<0.05).治療結束後3箇月,三組的有效率分彆變為:80.36%、60.47%、37.78%,差異均具有顯著性(P<0.05).結論 咪唑斯汀聯閤自血療法或卡介菌多糖覈痠治療慢性蕁痳疹能提高有效率、降低複髮率,前者更優,不良副反應少,值得推廣.
목적 탐토삼충불동방법치료만성담마진적근、원기료효화안전성.방법 장환자수궤분위삼조,삼조환자균구복미서사정편10 mg,매천1차,련용36천.a조:56례,재구복기출상가용자혈치료,취환자정맥혈3 ml립즉기주,격천1차,공18차;b조:45례,재구복기출상가용잡개균다당핵산주사액2ml기주,격천1차,련용18차;c조:43례,단순구복.재치료결속시화결속후3개월분별진행림상료효평개화안전성분석.결과 치료결속시삼조적유효솔분별위:78.57%、76.74%、55.56%,전량조상비차이무현저성(P>0.05),이여c조비교차이균구유현저성(P<0.05).치료결속후3개월,삼조적유효솔분별변위:80.36%、60.47%、37.78%,차이균구유현저성(P<0.05).결론 미서사정연합자혈요법혹잡개균다당핵산치료만성담마진능제고유효솔、강저복발솔,전자경우,불량부반응소,치득추엄.
Objective To compare the clinical effects of three different methods for chronic urticaria treatment. Methods The chronic urticaria were randomly divided into there groups. The first group astreated with awhole blood 3 ml every two days with intramuscular and mizolastine 10 mg/d for 36 days; the second group as treated with BCG-PSN 2 ml every two days with intramuscular and mizolastine 10 mg/d for 36 days; the third group was treated with mizolastine 10 mg/d only for 36 days. Results The efficient rates of 3 groups were 78.57%,76.74% and 55.56% respectively. There was significant difference in the three groups ,and there was also significant difference in the three groups after the treatment in three months. Conclusion It showed that the treatment of mizolastine and autologous whole blood or BCG-PSN is safe and effective for chronic urticaria which should be extended for application.